bpMedManage: Digital Technology for Hypertension Medication Adherence
This study, called bpMedManage, is testing a smartphone app designed to help older adults with mild cognitive impairment (MCI) remember to take their high blood pressure (hypertension) medications. We want to see if using this app, called bpMedManage-S, can improve how consistently people take their medicine compared to another group (bpMedManage-P). We are looking for 100 people aged 60 or older who live in the community, speak English, have some memory challenges, manage at least one blood pressure medication, and use a smartphone. We will measure medication adherence at 4 and 12 weeks to see if the app helps.
- Study design
- This is an interventional study with 100 participants. It is a randomized controlled trial, meaning participants will be assigned to one of two groups by chance.
- What's involved
- Participants will use a smartphone application with medication reminders and receive educational information for 16 weeks.
- Compensation
- Not stated in the trial record.
- Follow-up
- Medication adherence will be measured at Week 4 and Week 12.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
bpMedManage: Digital Technology to Support Adherence to Hypertension Medications
At a glance
Conditions
NCT06307574
Where you'd take part
This study runs at 2 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
University of Arizona
Tucson, Arizonastudy coordinator listed
Recruiting
University of Illinois, Urbana-Champaign
Champaign, Illinoisstudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Kathleen Insel, PhD · PRINCIPAL_INVESTIGATOR · University of Arizona
- Raksha Mudar, PhD · PRINCIPAL_INVESTIGATOR · University of Illinois, Urbana-Champaign
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Change in medication adherence measured by the Medication Event Monitoring System (MEMS® Cap)Week 4, Week 12
A device used to monitor medication adherence. The medication event monitoring system (MEMS) is a cap that fits on medication bottles and records the time and date each time the bottle is opened. Adherence data by MEMS® monitoring will be downloaded to a study laptop from all participants' MEMS® Cap via a USB connected MEMS® cap reader/communicator.
- Change in self-reported medication adherence measured by the Medication Adherence Report Scale-5 (MARS-5© Professor Rob Horne)Week 4, Week 12
5 items on a 5-point rating scale to assess participant's medication adherence, with lower scores indicating a lower level of adherence.